DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Mease P, Hall S, FitzGerald O. et al.
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
N Engl J Med 2017;
377 (16) 1537-1550.
We do not assume any responsibility for the contents of the web pages of other providers.